Calcification of abdominal aorta is a high risk underappreciated cardiovascular disease factor in a general population

Background Abdominal aortic calcification (AAC) is an important contributor to cardiovascular disease, however, prevalence of the pathology, risk factors, and disease outcomes in a general population have not been systematically analyzed.

Methods We have analyzed the prevalence of AAC in the UK Biobank cohort using machine learning models across 38,264 whole body dual-energy X-ray absorptiometry (DEXA) scans. We associated severity of calcification across a wide range of physiological parameters, clinical biomarkers, and environmental risk factors (406 in total). We further performed a rare and common variant genetic association study to identify genetic loci relevant to AAC and evaluated the prognostic value of AAC across 174 disease classes.

Results We find that AAC is highly prevalent in a general population (>10.4% of the cohort) despite low prevalence of diabetes (2.5%) and CKD (0.5%). Increased level of AAC is a strong prognostic indicator of a wide range of cardiovascular outcomes, including stenosis of precerebral arteries (HR∼1.5), myocardial infarction (HR∼1.36), ischemic heart disease (HR∼1.3), and chronic obstructive pulmonary disease (HR∼1.3). We report four genetic loci associated with AAC, three of which have not been previously reported. Surprisingly, we find that elevated but still within clinically normal levels of serum phosphate, serum calcium, and glycated hemoglobin are linked to increased vascular calcification.

Conclusions By our estimate, AAC is an LDL-independent risk factor for cardiovascular outcomes, with risk similar to elevated LDL. Development of anti-calcification therapeutics would complement lipid lowering strategies in reducing CVD burden.